Cardiac stem cells could be an effective treatment for a common but difficult-to-treat type of heart failure, a new study from the Cedars-Sinai Heart Institute shows. The study has led to clearance by the US Food and Drug Administration for an Investigational New Drug application to test the cells in patients.